This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Krueppel-like factor 15.
Is a repressor of CTGF expression, involved in the management of cardiac fibrosis. It is also involved in the management of cardiac hypertrophy acting through the inhibition of MEF2A and GATA4 (By similarity).
Human | |
---|---|
Gene Name: | KLF15 |
Uniprot: | Q9UIH9 |
Entrez: | 28999 |
Belongs to: |
---|
Sp1 C2H2-type zinc-finger protein family |
DKFZp779M1320; kidney-enriched Kruppel-like factor; KKLFKidney-enriched krueppel-like factor; Krueppel-like factor 15; Kruppel-like factor 15
Mass (kDA):
43.992 kDA
Human | |
---|---|
Location: | 3q21.3 |
Sequence: | 3; NC_000003.12 (126288121..126357408, complement) |
Highly expressed in liver, skeletal muscle, and kidney. Expressed in cardiomyocytes. Expression is highly reduced in cardiac tissue of patients with non-ischemic cardiomyopathy and aortic aneurysm, and in glomerular disease. Not expressed in bone marrow or lymphoid tissues.
Nucleus.
PMID: 10982849 by Uchida S., et al. Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Kruppel-like factor, a novel zinc finger repressor.
PMID: 17438289 by Fisch S., et al. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy.